Development of a high resolution melting method for the detection of genetic variations in Long QT Syndrome

Clinica Chimica Acta

Volumn 412, Issue 1-2, 2011, Pages 203-207

  Millat, Gilles ^a,b   Chanavat, Valérie ^a   Créhalet, Hervé ^a,b   Rousson, Robert ^a,b  

^a HOSPICES CIVILS DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

DHPLC; High resolution melting; Long QT Syndrome; Molecular diagnosis; Mutations; Polymorphisms

Indexed keywords

GENOMIC DNA; POTASSIUM CHANNEL; POTASSIUM CHANNEL KCNH2; POTASSIUM CHANNEL KCNQ1; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; EXON; GENE MUTATION; GENETIC POLYMORPHISM; GENETIC SCREENING; GENETIC VARIABILITY; HUMAN; INTERMETHOD COMPARISON; LONG QT SYNDROME; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; SENSITIVITY AND SENSIBILITY; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS;

EID: 78650513717     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.09.013     Document Type: Article

References (15)

1. Bokil N.J., Baisden J.M., Radford D.J., Summers K.M. Molecular genetics of long QT syndrome. Mol Genet Metab 2010, 101:1-8.
2. Schwartz P.J., Stramba-Badiale M., Crotti L., et al. Prevalence of the congenital long-QT syndrome. Circulation 2009, 120:1761-1767.
3. Splawski I., Shen J., Timothy K.W., et al. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 2000, 102:1178-1185.
4. Jongbloed R., Marcelis C., Velter C., Doevendans P., Geraedts J., Smeets H. DHPLC analysis of potassium ion channel genes in congenital long QT syndrome. Hum Mutat 2002, 20:382-391.
5. Ning L., Moss A., Zareba W., et al. Denaturing high-performance liquid chromatography quickly and reliably detects cardiac ion channel mutations in long QT syndrome. Genet Test 2003, 7:249-253.
6. Millat G., Chevalier P., Restier-Miron L., et al. Spectrum of pathogenic mutations and associated polymorphisms in a cohort of 44 unrelated patients with long QT syndrome. Clin Genet 2006, 70:214-227.
7. Kapplinger J.D., Tester D.J., Salisbury B.A., et al. Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm 2009, 6:1297-1303.
8. Millat G., Chanavat V., Rodriguez-Lafrasse C., Rousson R. Rapid, sensitive and inexpensive detection of SCN5A genetic variations by high resolution melting analysis. Clin Biochem 2009, 42:491-499.
9. Erali M., Wittwer C.T. High resolution melting analysis for gene scanning. Methods 2010, 50:250-261.
10. Poland D. Recursion relation generation of probability profiles for specific-sequence macromolecules with long-range correlations. Biopolymers 1974, 13:1859-1871.
11. Montgomery J.L., Sanford L.N., Wittwer C.T. High-resolution DNA melting analysis in clinical research and diagnostics. Expert Rev Mol Diagn 2010, 10:219-240.
12. Millat G., Chanavat V., Julia S., Crehalet H., Bouvagnet P., Rousson R. Validation of high-resolution DNA melting analysis for mutation scanning of the LMNA gene. Clin Biochem 2009, 42:892-898.
13. Lin S.Y., Su Y.N., Hung C.C., et al. Mutation spectrum of 122 hemophilia A families from Taiwanese population by LD-PCR, DHPLC, multiplex PCR and evaluating the clinical application of HRM. BMC Med Genet 2008, 9:53.
14. Sestini R., Provenzano A., Bacci C., et al. NF2 mutation screening by denaturing high-performance liquid chromatography and high-resolution melting analysis. Genet Test 2008, 12:311-318.
15. Audrezet M.P., Dabricot A., Le Marechal C., Ferec C. Validation of high-resolution DNA melting analysis for mutation scanning of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. J Mol Diagn 2008, 10:424-434.